$CLOW
Cloudweb, Inc.

2023 Q4 Form 10-Q Financial Statement

#000164033423001930 Filed on October 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.550K $9.150K
YoY Change -3.93% 21.03%
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.550K $8.550K $9.150K
YoY Change -68.8% -6.56% 21.03%
Operating Profit -$9.142K
YoY Change -7.96%
Interest Expense -$9.140K $9.140K $9.142K
YoY Change 0.0% -0.02% -7.96%
% of Operating Profit
Other Income/Expense, Net -$9.140K -$9.142K
YoY Change -0.02%
Pretax Income -$17.69K -$18.29K
YoY Change -51.59% 4.57%
Income Tax
% Of Pretax Income
Net Earnings -$17.69K -$17.69K -$18.29K
YoY Change -51.59% -3.29% 4.57%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$617.20
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares 27.82M shares
Diluted Shares Outstanding 27.82M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.76K $54.71K $56.61K
YoY Change -3.18% -3.36% -0.4%
Accrued Expenses $106.1K $208.2K $87.94K
YoY Change 15.8% 136.73% -34.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $72.41K
YoY Change -100.0% -100.0%
Long-Term Debt Due $155.6K $155.6K $155.6K
YoY Change 0.0% 0.0% -0.46%
Total Short-Term Liabilities $570.5K $552.8K $456.6K
YoY Change 15.7% 21.08% 21.13%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $570.5K $552.8K $456.6K
Total Long-Term Liabilities $67.33K $67.33K $67.33K
Total Liabilities $637.9K $620.2K $523.9K
YoY Change 13.81% 18.38% 17.93%
SHAREHOLDERS EQUITY
Retained Earnings -$233.4M -$233.4M -$233.3M
YoY Change 0.03% 0.04% 81.13%
Common Stock $237.9M $237.9M $237.9M
YoY Change 0.0% 0.0% 85.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$637.9K -$620.2K -$523.9K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$17.69K -$17.69K -$18.29K
YoY Change -51.59% -3.29% 4.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$26.11K -$12.15K
YoY Change 7.23% 177.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.11K 12.15K
YoY Change 7.23% 177.4%
NET CHANGE
Cash From Operating Activities -26.11K -12.15K
Cash From Investing Activities
Cash From Financing Activities 26.11K 12.15K
Net Change In Cash 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$26.11K -$12.15K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-488974 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-523901 usd
CY2022Q3 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2023Q3 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27819385 shares
CY2022Q3 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
29632572 shares
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27819385 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-560442 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21443 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-581885 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-602478 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001619227
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-199193
dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
963-7749
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-18292 usd
us-gaap Net Income Loss
NetIncomeLoss
-59726 usd
us-gaap Net Income Loss
NetIncomeLoss
-66455 usd
CY2023Q3 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
25291811 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-17690 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-620168 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 usd
CY2022Q1 clow Share Issuance For Director Compensation Amount
ShareIssuanceForDirectorCompensationAmount
0 usd
CY2022Q2 clow Share Issuance For Repayment Of Convertible Note Amount
ShareIssuanceForRepaymentOfConvertibleNoteAmount
2500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19135 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-505609 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-18292 usd
us-gaap Profit Loss
ProfitLoss
-59726 usd
us-gaap Profit Loss
ProfitLoss
-66455 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4950 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
497 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27127 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27324 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37549 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37450 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37549 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37450 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37549 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37450 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
104250000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2500 usd
CY2022 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2023Q3 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
105764 usd
CY2022Q4 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
89464 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55326667 shares
CY2023Q3 clow Related Party Current Liabilities
RelatedPartyCurrentLiabilities
134309 usd
CY2022Q4 clow Related Party Current Liabilities
RelatedPartyCurrentLiabilities
96760 usd
clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
CY2022 clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2022 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2023Q3 clow Less Debt Discount
LessDebtDiscount
0 usd
CY2022Q4 clow Less Debt Discount
LessDebtDiscount
-1184 usd
CY2023Q3 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
153482 usd
CY2022Q4 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
154798 usd
CY2023Q3 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-153482 usd
CY2022Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares

Files In Submission

Name View Source Status
0001640334-23-001930-index-headers.html Edgar Link pending
0001640334-23-001930-index.html Edgar Link pending
0001640334-23-001930.txt Edgar Link pending
0001640334-23-001930-xbrl.zip Edgar Link pending
clow-20230930.xsd Edgar Link pending
clow_10q.htm Edgar Link pending
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
clow-20230930_pre.xml Edgar Link unprocessable
clow-20230930_def.xml Edgar Link unprocessable
clow-20230930_lab.xml Edgar Link unprocessable
clow-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clow_10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending